Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome
Konstantin Uhlig, Ljupcho Efremov, Jörn Tongers, Stefan Frantz, Rafael Mikolajczyk, Daniel Sedding, Julia Schümann
Abstract
Cardiogenic shock (CS) and low cardiac output syndrome (LCOS) are potentially life-threatening complications of acute myocardial infarction (AMI), heart failure (HF) or cardiac surgery. While there is solid evidence for the treatment of other cardiovascular diseases of acute onset, treatment strategies in haemodynamic instability due to CS and LCOS remains less robustly supported by the given scientific literature. Therefore, we have analysed the current body of evidence for the treatment of CS or LCOS with inotropic and/or vasodilating agents. This is the second update of a Cochrane review originally published in 2014.
Topics & Concepts
Cardiogenic shockInotropeMedicineCardiologyVasodilationShock (circulatory)Internal medicineMyocardial infarctionMechanical Circulatory Support DevicesCardiac electrophysiology and arrhythmiasCardiac Arrest and Resuscitation